Melatonin and Neonatal Sepsis: A Promising Antioxidant Adjuvant Agent

American Journal of Perinatology

Volumn 34, Issue 14, 2017, Pages 1382-1388

  D'Angelo, Gabriella ^a   Marseglia, Lucia ^a   Reiter, Russel J ^b   Buonocore, Giuseppe ^c   Gitto, Eloisa ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b University of Texas Health Science Center   (United States)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

antioxidant; melatonin; newborn; oxidative stress; sepsis

Indexed keywords

ANTIOXIDANT; MELATONIN;

HUMAN; NEWBORN; NEWBORN SEPSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE MODEL; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; HUMANS; MELATONIN; NEONATAL SEPSIS; TREATMENT OUTCOME;

EID: 85023759506     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0037-1604244     Document Type: Review

References (87)

1. Perez E. M. Weisman L. E. Novel approaches to the prevention and therapy of neonatal bacterial sepsis. Clin Perinatol: 1997; 24 01 213 229
2. Saugstad O. D. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res: 1988; 23 02 143 150
3. Haynes R. L. Folkerth R. D. Keefe R. J., et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol: 2003; 62 05 441 450
4. Clyman R. I. Saugstad O. D. Mauray F. Reactive oxygen metabolites relax the lamb ductus arteriosus by stimulating prostaglandin production. Circ Res: 1989; 64 01 1 8
5. Bentlin M. R. de Souza Rugolo L. MS. Late-onset sepsis: epidemiology, evaluation, and outcome. Neoreviews: 2010; 11 08 e426 e435
6. Lush C. W. Kvietys P. R. Microvascular dysfunction in sepsis. Microcirculation: 2000; 7 02 83 101
7. Abraham E. Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med: 2007; 35 10 2408 2416
8. Wendel M. Heller A. R. Mitochondrial function and dysfunction in sepsis. Wien Med Wochenschr: 2010; 160 (5-6): 118 123
9. Galley H. F. Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis. Crit Care: 2010; 14 04 230
10. Reiter R. J. Paredes S. D. Manchester L. C. Tan D. X. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol: 2009; 44 04 175 200
11. Marseglia L. Aversa S. Barberi I., et al. High endogenous melatonin levels in critically ill children: a pilot study. J Pediatr: 2013; 162 02 357 360
12. Gitto E. Marseglia L. Manti S., et al. Protective role of melatonin in neonatal diseases. Oxid Med Cell Longev: 2013; 2013 980374
13. Galano A. Tan D. X. Reiter R. J. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res: 2013; 54 03 245 257
14. Venegas C. García J. A. Escames G., et al. Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res: 2012; 52 02 217 227
15. Víctor V. M. Espulgues J. V. Hernández-Mijares A. Rocha M. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. Infect Disord Drug Targets: 2009; 9 04 376 389
16. Gitto E. Aversa S. Reiter R. J. Barberi I. Pellegrino S. Update on the use of melatonin in pediatrics. J Pineal Res: 2011; 50 01 21 28
17. Bersani I. Auriti C. Ronchetti M. P. Prencipe G. Gazzolo D. Dotta A. Use of early biomarkers in neonatal brain damage and sepsis: state of the art and future perspectives. BioMed Res Int: 2015; 2015 253520
18. Crouser E. D. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion: 2004; 4 (5-6): 729 741
19. Rinaldi S. Landucci F. De Gaudio A. R. Antioxidant therapy in critically septic patients. Curr Drug Targets: 2009; 10 09 872 880
20. Mishra U. K. Jacobs S. E. Doyle L. W. Garland S. M. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed: 2006; 91 03 F208 F212
21. Berner R. Tüxen B. Clad A. Forster J. Brandis M. Elevated gene expression of interleukin-8 in cord blood is a sensitive marker for neonatal infection. Eur J Pediatr: 2000; 159 03 205 210
22. Schultz C. Temming P. Bucsky P. Göpel W. Strunk T. Härtel C. Immature anti-inflammatory response in neonates. Clin Exp Immunol: 2004; 135 01 130 136
23. Lowes D. A. Webster N. R. Murphy M. P. Galley H. F. Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br J Anaesth: 2013; 110 03 472 480
24. Galley H. F. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth: 2011; 107 01 57 64
25. Hirsiger S. Simmen H. P. Werner C. M. Wanner G. A. Rittirsch D. Danger signals activating the immune response after trauma. Mediators Inflamm: 2012; 2012 315941
26. Prauchner C. A. Oxidative stress in sepsis: pathophysiological implications justifying antioxidant co-therapy. Burns: 2017; 43 03 471 485
27. von Dessauer B. Bongain J. Molina V. Quilodrán J. Castillo R. Rodrigo R. Oxidative stress as a novel target in pediatric sepsis management. J Crit Care: 2011; 26 01 103.e1 103.e7
28. Alonso de Vega J. M. Díaz J. Serrano E. Carbonell L. F. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med: 2002; 30 08 1782 1786
29. Goode H. F. Cowley H. C. Walker B. E. Howdle P. D. Webster N. R. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med: 1995; 23 04 646 651
30. Parrillo J. E. Burch C. Shelhamer J. H. Parker M. M. Natanson C. Schuette W. A circulating myocardial depressant substance in human with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest: 1985; 76 04 1539 1553
31. Parratt J. R. Nitric oxide in sepsis and endotoxaemia. J Antimicrob Chemother: 1998; 41 (Suppl A): 31 39
32. Kumar A. Brar R. Wang P., et al. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol: 1999; 276 (1 Pt 2): R265 R276
33. Brealey D. Brand M. Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet: 2002; 360 (9328): 219 223
34. Brown G. C. Borutaite V. Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res: 2007; 75 02 283 290
35. Delanghe J. R. Speeckaert M. M. Translational research and biomarkers in neonatal sepsis. Clin Chim Acta: 2015; 451 (Pt 0A): 46 64
36. Sakr Y. Reinhart K. Bloos F., et al. Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anaesth: 2007; 98 06 775 784
37. Borrelli E. Roux-Lombard P. Grau G. E., et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med: 1996; 24 03 392 397
38. Manzanares W. Dhaliwal R. Jiang X. Murch L. Heyland D. K. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care: 2012; 16 02 R66
39. Lerner A. B. Case J. D. Takahashi Y. Isolation of melatonin, a pineal factor that lightens melanocytes. J Am Chem Soc: 1958; 80 2587 2592
40. Reiter R. J. Tan D. X. Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res: 2010; 181 127 151
41. Gitto E. Pellegrino S. Gitto P. Barberi I. Reiter R. J. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res: 2009; 46 02 128 139
42. Jan J. E. Reiter R. J. Wasdell M. B. Bax M. The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders. J Pineal Res: 2009; 46 01 1 7
43. Pandi-Perumal S. R. Trakht I. Spence D. W. Srinivasan V. Dagan Y. Cardinali D. P. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. Nat Clin Pract Neurol: 2008; 4 08 436 447
44. Dauchy R. T. Blask D. E. Dauchy E. M., et al. Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts. J Pineal Res: 2009; 47 01 32 42
45. Gitto E. Marseglia L. D'Angelo G., et al. Melatonin versus midazolam premedication in children undergoing surgery: A pilot study. J Paediatr Child Health: 2016; 52 03 291 295
46. Gitto E. Karbownik M. Reiter R. J., et al. Effects of melatonin treatment in septic newborns. Pediatr Res: 2001; 50 06 756 760
47. Marseglia L. Cuppari C. Manti S., et al. Atopic dermatitis: melatonin as potential treatment. J Biol Regul Homeost Agents: 2015; 29 (2, Suppl 1) 142 149
48. Li Volti G. Musumeci T. Pignatello R., et al. Antioxidant potential of different melatonin-loaded nanomedicines in an experimental model of sepsis. Exp Biol Med (Maywood): 2012; 237 06 670 677
49. Shang Y. Xu S. P. Wu Y., et al. Melatonin reduces acute lung injury in endotoxemic rats. Chin Med J (Engl): 2009; 122 12 1388 1393
50. Wu J. Y. Tsou M. Y. Chen T. H. Chen S. J. Tsao C. M. Wu C. C. Therapeutic effects of melatonin on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats. J Pineal Res: 2008; 45 01 106 116
51. Escames G. Acuña-Castroviejo D. López L. C., et al. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol: 2006; 58 09 1153 1165
52. Wu C. C. Chiao C. W. Hsiao G. Chen A. Yen M. H. Melatonin prevents endotoxin-induced circulatory failure in rats. J Pineal Res: 2001; 30 03 147 156
53. Carrillo-Vico A. Lardone P. J. Naji L., et al. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J Pineal Res: 2005; 39 04 400 408
54. García J. A. Ortiz F. Miana J., et al. Contribution of inducible and neuronal nitric oxide synthases to mitochondrial damage and melatonin rescue in LPS-treated mice. J Physiol Biochem: 2017; 73 02 235 244
55. Sener G. Toklu H. Kapucu C., et al. Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg Today: 2005; 35 01 52 59
56. Ortiz F. García J. A. Acuña-Castroviejo D., et al. The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS. J Pineal Res: 2014; 56 01 71 81
57. Fink T. Glas M. Wolf A., et al. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis. Crit Care Med: 2014; 42 01 e22 e31
58. Doerrier C. García J. A. Volt H., et al. Permeabilized myocardial fibers as model to detect mitochondrial dysfunction during sepsis and melatonin effects without disruption of mitochondrial network. Mitochondrion: 2016; 27 56 63
59. Srinivasan V. Pandi-Perumal S. R. Spence D. W. Kato H. Cardinali D. P. Melatonin in septic shock: some recent concepts. J Crit Care: 2010; 25 04 656.e1 656.e6
60. Galano A. Tan D. X. Reiter R. J. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res: 2011; 51 01 1 16
61. Reiter R. J. Tan D. X. Rosales-Corral S. Manchester L. C. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem: 2013; 13 03 373 384
62. Galley H. F. Lowes D. A. Allen L. Cameron G. Aucott L. S. Webster N. R. Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J Pineal Res: 2014; 56 04 427 438
63. Batra S. Kumar R. Kapoor A. K. Ray G. Alterations in antioxidant status during neonatal sepsis. Ann Trop Paediatr: 2000; 20 01 27 33
64. Seema K. R. Kumar R. Mandal R. N., et al. Serum TNF-alpha and free radical scavengers in neonatal septicemia. Indian J Pediatr: 1999; 66 04 511 516
65. Cancelier A. C. Petronilho F. Reinke A., et al. Inflammatory and oxidative parameters in cord blood as diagnostic of early-onset neonatal sepsis: a case-control study. Pediatr Crit Care Med: 2009; 10 04 467 471
66. Reiter R. J. Tan D. X. Osuna C. Gitto E. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci: 2000; 7 06 444 458
67. Rodriguez C. Mayo J. C. Sainz R. M., et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res: 2004; 36 01 1 9
68. El Frargy M. El-Sharkawy H. M. Attia G. F. Use of melatonin as an adjuvant therapy in neonatal sepsis. J Neonatal Perinatal Med: 2015; 8 03 227 232
69. El-Mashad A. R. Elmahdy H. El-Dib M. Elbatch M. Aly H. Can melatonin be used as a marker for neonatal sepsis? J Matern Fetal Neonatal Med: 2016; 29 17 2870 2873
70. Lowes D. A. Almawash A. M. Webster N. R. Reid V. L. Galley H. F. Melatonin and structurally similar compounds have differing effects on inflammation and mitochondrial function in endothelial cells under conditions mimicking sepsis. Br J Anaesth: 2011; 107 02 193 201
71. López A. García J. A. Escames G., et al. Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res: 2009; 46 02 188 198
72. Volt H. García J. A. Doerrier C., et al. Same molecule but different expression: aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin. J Pineal Res: 2016; 60 02 193 205
73. Ortiz F. Acuña-Castroviejo D. Doerrier C., et al. Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis. J Pineal Res: 2015; 58 01 34 49
74. Lorente L. Martín M. M. Abreu-González P., et al. Serum melatonin levels are associated with mortality in severe septic patients. J Crit Care: 2015; 30 04 860.e1 860.e6
75. Bagci S. Horoz ÖÖ. Yildizdas D. Reinsberg J. Bartmann P. Müller A. Melatonin status in pediatric intensive care patients with sepsis. Pediatr Crit Care Med: 2012; 13 02 e120 e123
76. Gitto E. Reiter R. J. Karbownik M., et al. Causes of oxidative stress in the pre- and perinatal period. Biol Neonate: 2002; 81 03 146 157
77. Saugstad O. D. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr: 1996; 85 01 1 4
78. Shim H. Jang J. Y. Lee S. H. Lee J. G. Correlation of the oxygen radical activity and antioxidants and severity in critically ill surgical patients - study protocol. World J Emerg Surg: 2013; 8 01 18
79. Huet O. Dupic L. Harrois A. Duranteau J. Oxidative stress and endothelial dysfunction during sepsis. Front Biosci (Landmark Ed): 2011; 16 1986 1995
80. Martín M. Macías M. Escames G., et al. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res: 2000; 28 04 242 248
81. Fulia F. Gitto E. Cuzzocrea S., et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res: 2001; 31 04 343 349
82. Gitto E. Reiter R. J. Cordaro S. P., et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol: 2004; 21 04 209 216
83. Gitto E. Reiter R. J. Amodio A., et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res: 2004; 36 04 250 255
84. Gitto E. Romeo C. Reiter R. J., et al. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg: 2004; 39 02 184 189
85. Jahnke G. Marr M. Myers C. Wilson R. Travlos G. Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci: 1999; 50 02 271 279
86. Sánchez-Barceló E. J. Mediavilla M. D. Tan D. X. Reiter R. J. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem: 2010; 17 19 2070 2095
87. Hu W. Deng C. Ma Z., et al. Utilizing melatonin to combat bacterial infections and septic injury. Br J Pharmacol: 2017; 174 09 754 768